I would love to know what assumptions IHL are making regarding patient participation levels and treatment costs (ie revenue) for the new clinic. I read somewhere that the cost of treatment is expected to range b/w 10k and 30k per candidate (can't remember where I read this so it may be wrong. It is also admittedly a large range and difficult to be accurate given it hasn't been done on a large scale yet).
With 700,000 people in Australia currently living with PTSD or TRD, the revenue potential is off the charts. Even if we reach 5% at 20k per treatment, that's 700m revenue. Not only that, imagine helping that many people improve their quality of life.
The long-term cost and impact on society of having that many suffers makes 20k seem pretty cheap, provided it works of course.
GLTAH.
R
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-16655
-
- There are more pages in this discussion • 3,242 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online